Skip to main content
Jesica (Christensen) Herrick, MD, Infectious Disease, Chicago, IL

JesicaAllyn(Christensen)HerrickMD

Infectious Disease Chicago, IL

Physician

Are you Dr. Herrick?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 64 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    808 S Wood St
    MSC 735
    Chicago, IL 60612
    Phone+1 312-996-3418
    Fax+1 312-413-1421

Summary

  • Dr. Jesica (Christensen) Herrick, MD is an infectious disease specialist in Chicago, Illinois. She is currently licensed to practice medicine in Illinois. She is affiliated with University of Illinois Hospital.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2009 - 2011
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2005 - 2008
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 2005

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2005 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Kids’ Vaccines Are ‘A Game Changer,’ Experts Say—Here’s What Else Needs to Happen to End the Covid Pandemic
    Kids’ Vaccines Are ‘A Game Changer,’ Experts Say—Here’s What Else Needs to Happen to End the Covid PandemicJune 28th, 2022
  • How Covid Vaccines for Teenagers Underneath 5 Might Help Finish the Pandemic: Consultants
    How Covid Vaccines for Teenagers Underneath 5 Might Help Finish the Pandemic: ConsultantsJune 28th, 2022
  • UIC Opens Phase 3 Monoclonal Antibody Clinical Trial
    UIC Opens Phase 3 Monoclonal Antibody Clinical TrialOctober 29th, 2020